Priming of Sorafenib Prior to Radiofrequency Ablation Does Not Increase Treatment Effect in Hepatocellular Carcinoma is a research paper published in Digestive Diseases and Sciences (2021). On theSindex it has a DataRank of 0.332. It has been cited 5 times, with 5 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.269
From this paper's citation signal
Citation Network Contribution
0.0636
From 4 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 5 citers.
National Institutes of Health
Grant: K23CA139005
National Institutes of Health
Grant: 5K23CA139005-02
Optimizing localized therapy for primary liver cancer: a clinical trial and model
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals